{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T01:33:14Z","timestamp":1788139994664,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T00:00:00Z","timestamp":1589587200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T00:00:00Z","timestamp":1589587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Wuhan Municipal Health Commission","award":["No. WZ16A01"],"award-info":[{"award-number":["No. WZ16A01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s11255-020-02485-z","type":"journal-article","created":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T11:37:41Z","timestamp":1589629061000},"page":"1389-1401","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Vinpocetine reduces cisplatin-induced acute kidney injury through inhibition of NF\u2013\u03baB pathway and activation of Nrf2\/ARE pathway in rats"],"prefix":"10.1007","volume":"52","author":[{"given":"Wenjing","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weinan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JingJing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengju","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenli","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,16]]},"reference":[{"issue":"23","key":"2485_CR1","doi-asserted-by":"publisher","first-page":"5651","DOI":"10.1158\/1078-0432.ccr-16-0247","volume":"22","author":"EH Stover","year":"2016","unstructured":"Stover EH, Konstantinopoulos PA, Matulonis UA, Swisher EM (2016) Biomarkers of response and resistance to DNA repair targeted therapies. Clin Cancer Res 22(23):5651\u20135660. https:\/\/doi.org\/10.1158\/1078-0432.ccr-16-0247","journal-title":"Clin Cancer Res"},{"key":"2485_CR2","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","volume":"740","author":"S Dasari","year":"2014","unstructured":"Dasari S, Tchounwou PB (2014) Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol 740:364\u2013378. https:\/\/doi.org\/10.1016\/j.ejphar.2014.07.025","journal-title":"Eur J Pharmacol"},{"issue":"8","key":"2485_CR3","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrc2167","volume":"7","author":"L Kelland","year":"2007","unstructured":"Kelland L (2007) The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer 7(8):573\u2013584. https:\/\/doi.org\/10.1038\/nrc2167","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"2485_CR4","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3109\/10408444.2011.602662","volume":"41","author":"PD Sanchez-Gonzalez","year":"2011","unstructured":"Sanchez-Gonzalez PD, Lopez-Hernandez FJ, Lopez-Novoa JM, Morales AI (2011) An integrative view of the pathophysiological events leading to cisplatin nephrotoxicity. Crit Rev Toxicol 41(10):803\u2013821. https:\/\/doi.org\/10.3109\/10408444.2011.602662","journal-title":"Crit Rev Toxicol"},{"issue":"5","key":"2485_CR5","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/S0270-9295(03)00089-5","volume":"23","author":"I Arany","year":"2003","unstructured":"Arany I, Safirstein RL (2003) Cisplatin nephrotoxicity. Semin Nephrol 23(5):460\u2013464","journal-title":"Semin Nephrol"},{"issue":"11","key":"2485_CR6","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.1681\/asn.2015070827","volume":"27","author":"R Galgamuwa","year":"2016","unstructured":"Galgamuwa R, Hardy K, Dahlstrom JE, Blackburn AC, Wium E, Rooke M, Cappello JY, Tummala P, Patel HR, Chuah A, Tian L, McMorrow L, Board PG, Theodoratos A (2016) Dichloroacetate prevents cisplatin-induced nephrotoxicity without compromising cisplatin anticancer properties. J Am Soc Nephrol JASN 27(11):3331\u20133344. https:\/\/doi.org\/10.1681\/asn.2015070827","journal-title":"J Am Soc Nephrol JASN"},{"issue":"1","key":"2485_CR7","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/labinvest.2017.120","volume":"98","author":"XM Meng","year":"2018","unstructured":"Meng XM, Ren GL, Gao L, Yang Q, Li HD, Wu WF, Huang C, Zhang L, Lv XW, Li J (2018) NADPH oxidase 4 promotes cisplatin-induced acute kidney injury via ROS-mediated programmed cell death and inflammation. Lab Investig 98(1):63\u201378. https:\/\/doi.org\/10.1038\/labinvest.2017.120","journal-title":"Lab Investig"},{"issue":"11","key":"2485_CR8","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/S1567-5769(02)00058-9","volume":"2","author":"T Wang","year":"2002","unstructured":"Wang T, Zhang X, Li JJ (2002) The role of NF-kappaB in the regulation of cell stress responses. Int Immunopharmacol 2(11):1509\u20131520","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"2485_CR9","doi-asserted-by":"publisher","first-page":"R94","DOI":"10.1016\/s0960-9822(06)00046-7","volume":"7","author":"VR Baichwal","year":"1997","unstructured":"Baichwal VR, Baeuerle PA (1997) Activate NF-kappa B or die? Curr Biol CB 7(2):R94\u201396. https:\/\/doi.org\/10.1016\/s0960-9822(06)00046-7","journal-title":"Curr Biol CB"},{"issue":"49","key":"2485_CR10","doi-asserted-by":"publisher","first-page":"6853","DOI":"10.1038\/sj.onc.1203239","volume":"18","author":"HL Pahl","year":"1999","unstructured":"Pahl HL (1999) Activators and target genes of Rel\/NF-kappaB transcription factors. Oncogene 18(49):6853\u20136866. https:\/\/doi.org\/10.1038\/sj.onc.1203239","journal-title":"Oncogene"},{"issue":"3","key":"2485_CR11","doi-asserted-by":"publisher","first-page":"317","DOI":"10.2174\/1381612820666140826114601","volume":"21","author":"PR Heckman","year":"2015","unstructured":"Heckman PR, Wouters C, Prickaerts J (2015) Phosphodiesterase inhibitors as a target for cognition enhancement in aging and Alzheimer's disease: a translational overview. Curr Pharm Des 21(3):317\u2013331. https:\/\/doi.org\/10.2174\/1381612820666140826114601","journal-title":"Curr Pharm Des"},{"issue":"29","key":"2485_CR12","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1556\/oh.2007.28115","volume":"148","author":"E Bagoly","year":"2007","unstructured":"Bagoly E, Feher G, Szapary L (2007) The role of vinpocetine in the treatment of cerebrovascular diseases based in human studies. Orv Hetil 148(29):1353\u20131358. https:\/\/doi.org\/10.1556\/oh.2007.28115","journal-title":"Orv Hetil"},{"issue":"2","key":"2485_CR13","first-page":"376","volume":"43","author":"N Tamaki","year":"1985","unstructured":"Tamaki N, Matsumoto S (1985) Agents to improve cerebrovascular circulation and cerebral metabolism\u2013vinpocetine. Nihon Rinsho Jpn J Clin Med 43(2):376\u2013378","journal-title":"Nihon Rinsho Jpn J Clin Med"},{"key":"2485_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3389\/fnins.2011.00021","volume":"5","author":"AE Medina","year":"2011","unstructured":"Medina AE (2011) Therapeutic utility of phosphodiesterase type I inhibitors in neurological conditions. Front Neurosci 5:21. https:\/\/doi.org\/10.3389\/fnins.2011.00021","journal-title":"Front Neurosci"},{"key":"2485_CR15","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.neuroscience.2014.12.008","volume":"286","author":"S Sharma","year":"2015","unstructured":"Sharma S, Deshmukh R (2015) Vinpocetine attenuates MPTP-induced motor deficit and biochemical abnormalities in Wistar rats. Neuroscience 286:393\u2013403. https:\/\/doi.org\/10.1016\/j.neuroscience.2014.12.008","journal-title":"Neuroscience"},{"key":"2485_CR16","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ejphar.2014.03.032","volume":"732","author":"S Gupta","year":"2014","unstructured":"Gupta S, Sharma B (2014) Protective effects of phosphodiesterase-1 (PDE1) and ATP sensitive potassium (KATP) channel modulators against 3-nitropropionic acid induced behavioral and biochemical toxicities in experimental Huntingtons disease. Eur J Pharmacol 732:111\u2013122. https:\/\/doi.org\/10.1016\/j.ejphar.2014.03.032","journal-title":"Eur J Pharmacol"},{"key":"2485_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.cbi.2015.05.007","volume":"237","author":"KW Ruiz-Miyazawa","year":"2015","unstructured":"Ruiz-Miyazawa KW, Pinho-Ribeiro FA, Zarpelon AC, Staurengo-Ferrari L, Silva RL, Alves-Filho JC, Cunha TM, Cunha FQ, Casagrande R, Verri WA Jr (2015) Vinpocetine reduces lipopolysaccharide-induced inflammatory pain and neutrophil recruitment in mice by targeting oxidative stress, cytokines and NF-kappaB. Chem Biol Interact 237:9\u201317. https:\/\/doi.org\/10.1016\/j.cbi.2015.05.007","journal-title":"Chem Biol Interact"},{"issue":"21","key":"2485_CR18","doi-asserted-by":"publisher","first-page":"9795","DOI":"10.1073\/pnas.0914414107","volume":"107","author":"KI Jeon","year":"2010","unstructured":"Jeon KI, Xu X, Aizawa T, Lim JH, Jono H, Kwon DS, Abe J, Berk BC, Li JD, Yan C (2010) Vinpocetine inhibits NF-kappaB-dependent inflammation via an IKK-dependent but PDE-independent mechanism. Proc Natl Acad Sci USA 107(21):9795\u20139800. https:\/\/doi.org\/10.1073\/pnas.0914414107","journal-title":"Proc Natl Acad Sci USA"},{"key":"2485_CR19","doi-asserted-by":"publisher","first-page":"142","DOI":"10.4103\/ijpvm.IJPVM_5_19","volume":"10","author":"HM Al-Kuraishy","year":"2019","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Al-Nami MS (2019) Vinpocetine improves oxidative stress and pro-inflammatory mediators in acute kidney injury. Int J Prevent Med 10:142. https:\/\/doi.org\/10.4103\/ijpvm.IJPVM_5_19","journal-title":"Int J Prevent Med"},{"issue":"2","key":"2485_CR20","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1159\/000488964","volume":"43","author":"HDC Francescato","year":"2018","unstructured":"Francescato HDC, Almeida LF, Reis NG, Faleiros CM, Papoti M, Costa RS, Coimbra TM (2018) Previous exercise effects in cisplatin-induced renal lesions in rats. Kidney Blood Pressure Res 43(2):582\u2013593. https:\/\/doi.org\/10.1159\/000488964","journal-title":"Kidney Blood Pressure Res"},{"issue":"1","key":"2485_CR21","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.amjms.2017.08.004","volume":"355","author":"ME Ibrahim","year":"2018","unstructured":"Ibrahim ME, Bana EE, El-Kerdasy HI (2018) Role of bone marrow derived mesenchymal stem cells and the protective effect of silymarin in cisplatin-induced acute renal failure in rats. Am J Med Sci 355(1):76\u201383. https:\/\/doi.org\/10.1016\/j.amjms.2017.08.004","journal-title":"Am J Med Sci"},{"issue":"9","key":"2485_CR22","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1194\/jlr.M080465","volume":"59","author":"E Moreno-Gordaliza","year":"2018","unstructured":"Moreno-Gordaliza E, Esteban-Fernandez D, Lazaro A, Aboulmagd S, Humanes B, Tejedor A, Linscheid MW, Gomez-Gomez MM (2018) Lipid imaging for visualizing cilastatin amelioration of cisplatin-induced nephrotoxicity. J Lipid Res 59(9):1561\u20131574. https:\/\/doi.org\/10.1194\/jlr.M080465","journal-title":"J Lipid Res"},{"issue":"8","key":"2485_CR23","doi-asserted-by":"publisher","first-page":"e0135083","DOI":"10.1371\/journal.pone.0135083","volume":"10","author":"YM Choi","year":"2015","unstructured":"Choi YM, Kim HK, Shim W, Anwar MA, Kwon JW, Kwon HK, Kim HJ, Jeong H, Kim HM, Hwang D, Kim HS, Choi S (2015) Mechanism of cisplatin-induced cytotoxicity is correlated to impaired metabolism due to mitochondrial ROS generation. PLoS ONE 10(8):e0135083. https:\/\/doi.org\/10.1371\/journal.pone.0135083","journal-title":"PLoS ONE"},{"issue":"1","key":"2485_CR24","doi-asserted-by":"publisher","first-page":"e86057","DOI":"10.1371\/journal.pone.0086057","volume":"9","author":"H Pan","year":"2014","unstructured":"Pan H, Shen K, Wang X, Meng H, Wang C, Jin B (2014) Protective effect of metalloporphyrins against cisplatin-induced kidney injury in mice. PLoS ONE 9(1):e86057. https:\/\/doi.org\/10.1371\/journal.pone.0086057","journal-title":"PLoS ONE"},{"issue":"7","key":"2485_CR25","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.2215\/cjn.08070715","volume":"11","author":"S Latcha","year":"2016","unstructured":"Latcha S, Jaimes EA, Patil S, Glezerman IG, Mehta S, Flombaum CD (2016) Long-term renal outcomes after cisplatin treatment. Clin J Am Soc Nephrol CJASN 11(7):1173\u20131179. https:\/\/doi.org\/10.2215\/cjn.08070715","journal-title":"Clin J Am Soc Nephrol CJASN"},{"issue":"10","key":"2485_CR26","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1016\/s0959-8049(98)00224-x","volume":"34","author":"D Lebwohl","year":"1998","unstructured":"Lebwohl D, Canetta R (1998) Clinical development of platinum complexes in cancer therapy: an historical perspective and an update. Eur J Cancer 34(10):1522\u20131534. https:\/\/doi.org\/10.1016\/s0959-8049(98)00224-x","journal-title":"Eur J Cancer"},{"issue":"5","key":"2485_CR27","doi-asserted-by":"publisher","first-page":"F726","DOI":"10.1152\/ajprenal.2000.278.5.F726","volume":"278","author":"F Shiraishi","year":"2000","unstructured":"Shiraishi F, Curtis LM, Truong L, Poss K, Visner GA, Madsen K, Nick HS, Agarwal A (2000) Heme oxygenase-1 gene ablation or expression modulates cisplatin-induced renal tubular apoptosis. Am J Physiol Renal Physiol 278(5):F726\u2013736. https:\/\/doi.org\/10.1152\/ajprenal.2000.278.5.F726","journal-title":"Am J Physiol Renal Physiol"},{"issue":"1","key":"2485_CR28","doi-asserted-by":"publisher","first-page":"12","DOI":"10.2215\/cjn.02730313","volume":"9","author":"X Zeng","year":"2014","unstructured":"Zeng X, McMahon GM, Brunelli SM, Bates DW, Waikar SS (2014) Incidence, outcomes, and comparisons across definitions of AKI in hospitalized individuals. Clin J Am Soc Nephrol CJASN 9(1):12\u201320. https:\/\/doi.org\/10.2215\/cjn.02730313","journal-title":"Clin J Am Soc Nephrol CJASN"},{"issue":"10002","key":"2485_CR29","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/s0140-6736(15)00344-x","volume":"386","author":"L Yang","year":"2015","unstructured":"Yang L, Xing G, Wang L, Wu Y, Li S, Xu G, He Q, Chen J, Chen M, Liu X, Zhu Z, Yang L, Lian X, Ding F, Li Y, Wang H, Wang J, Wang R, Mei C, Xu J, Li R, Cao J, Zhang L, Wang Y, Xu J, Bao B, Liu B, Chen H, Li S, Zha Y, Luo Q, Chen D, Shen Y, Liao Y, Zhang Z, Wang X, Zhang K, Liu L, Mao P, Guo C, Li J, Wang Z, Bai S, Shi S, Wang Y, Wang J, Liu Z, Wang F, Huang D, Wang S, Ge S, Shen Q, Zhang P, Wu L, Pan M, Zou X, Zhu P, Zhao J, Zhou M, Yang L, Hu W, Wang J, Liu B, Zhang T, Han J, Wen T, Zhao M, Wang H (2015) Acute kidney injury in China: a cross-sectional survey. Lancet (London, England) 386(10002):1465\u20131471. https:\/\/doi.org\/10.1016\/s0140-6736(15)00344-x","journal-title":"Lancet (London, England)"},{"issue":"5","key":"2485_CR30","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s11596-017-1801-1","volume":"37","author":"SS Cao","year":"2017","unstructured":"Cao SS, Yan M, Hou ZY, Chen Y, Jiang YS, Fan XR, Fang PF, Zhang BK (2017) Danshen modulates Nrf2-mediated signaling pathway in cisplatin-induced renal injury. J Huazhong Univ Sci Technol Med Sci 37(5):761\u2013765. https:\/\/doi.org\/10.1007\/s11596-017-1801-1","journal-title":"J Huazhong Univ Sci Technol Med Sci"},{"issue":"33","key":"2485_CR31","doi-asserted-by":"publisher","first-page":"3583","DOI":"10.2174\/0929867324666170511120814","volume":"24","author":"M Guerrero-Hue","year":"2017","unstructured":"Guerrero-Hue M, Farre-Alins V, Palomino-Antolin A, Parada E, Rubio-Navarro A, Egido J, Egea J, Moreno JA (2017) Targeting Nrf2 in protection against renal disease. Curr Med Chem 24(33):3583\u20133605. https:\/\/doi.org\/10.2174\/0929867324666170511120814","journal-title":"Curr Med Chem"},{"issue":"32","key":"2485_CR32","doi-asserted-by":"publisher","first-page":"52078","DOI":"10.18632\/oncotarget.19107","volume":"8","author":"Z Zhou","year":"2017","unstructured":"Zhou Z, Liu C, Chen S, Zhao H, Zhou K, Wang W, Yuan Y, Li Z, Guo Y, Shen Z, Mei X (2017) Activation of the Nrf2\/ARE signaling pathway by probucol contributes to inhibiting inflammation and neuronal apoptosis after spinal cord injury. Oncotarget 8(32):52078\u201352093. https:\/\/doi.org\/10.18632\/oncotarget.19107","journal-title":"Oncotarget"},{"key":"2485_CR33","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.ejphar.2017.11.023","volume":"818","author":"Y Izumi","year":"2018","unstructured":"Izumi Y, Kataoka H, Inose Y, Akaike A, Koyama Y, Kume T (2018) Neuroprotective effect of an Nrf2-ARE activator identified from a chemical library on dopaminergic neurons. Eur J Pharmacol 818:470\u2013479. https:\/\/doi.org\/10.1016\/j.ejphar.2017.11.023","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"2485_CR34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/nrd1279","volume":"3","author":"M Karin","year":"2004","unstructured":"Karin M, Yamamoto Y, Wang QM (2004) The IKK NF-kappa B system: a treasure trove for drug development. Nat Rev Drug Discov 3(1):17\u201326. https:\/\/doi.org\/10.1038\/nrd1279","journal-title":"Nat Rev Drug Discov"},{"issue":"11","key":"2485_CR35","doi-asserted-by":"publisher","first-page":"4266","DOI":"10.1182\/blood-2005-09-3852","volume":"107","author":"K Nagashima","year":"2006","unstructured":"Nagashima K, Sasseville VG, Wen D, Bielecki A, Yang H, Simpson C, Grant E, Hepperle M, Harriman G, Jaffee B, Ocain T, Xu Y, Fraser CC (2006) Rapid TNFR1-dependent lymphocyte depletion in vivo with a selective chemical inhibitor of IKKbeta. Blood 107(11):4266\u20134273. https:\/\/doi.org\/10.1182\/blood-2005-09-3852","journal-title":"Blood"},{"issue":"2","key":"2485_CR36","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3390\/cancers2020483","volume":"2","author":"I Bellezza","year":"2010","unstructured":"Bellezza I, Mierla AL, Minelli A (2010) Nrf2 and NF-kappaB and their concerted modulation in cancer pathogenesis and progression. Cancers 2(2):483\u2013497. https:\/\/doi.org\/10.3390\/cancers2020483","journal-title":"Cancers"},{"issue":"4","key":"2485_CR37","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1158\/1541-7786.mcr-05-0261","volume":"4","author":"H Lu","year":"2006","unstructured":"Lu H, Ouyang W, Huang C (2006) Inflammation, a key event in cancer development. Mol Cancer Res MCR 4(4):221\u2013233. https:\/\/doi.org\/10.1158\/1541-7786.mcr-05-0261","journal-title":"Mol Cancer Res MCR"},{"issue":"12 Suppl","key":"2485_CR38","doi-asserted-by":"publisher","first-page":"2993s","DOI":"10.1093\/jn\/135.12.2993S","volume":"135","author":"YJ Surh","year":"2005","unstructured":"Surh YJ, Kundu JK, Na HK, Lee JS (3001s) Redox-sensitive transcription factors as prime targets for chemoprevention with anti-inflammatory and antioxidative phytochemicals. J Nutr 135(12 Suppl):2993s\u20133001s. https:\/\/doi.org\/10.1093\/jn\/135.12.2993S","journal-title":"J Nutr"},{"issue":"8","key":"2485_CR39","doi-asserted-by":"publisher","first-page":"719","DOI":"10.2217\/fon-2017-0584","volume":"14","author":"J Chang","year":"2018","unstructured":"Chang J, Zhang Y, Li Y, Lu K, Shen Y, Guo Y, Qi Q, Wang M, Zhang S (2018) NrF2\/ARE and NF-kappaB pathway regulation may be the mechanism for lutein inhibition of human breast cancer cell. Fut Oncol (London, England) 14(8):719\u2013726. https:\/\/doi.org\/10.2217\/fon-2017-0584","journal-title":"Fut Oncol (London, England)"},{"issue":"5","key":"2485_CR40","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.bbamcr.2008.01.002","volume":"1783","author":"GH Liu","year":"2008","unstructured":"Liu GH, Qu J, Shen X (2008) NF-kappaB\/p65 antagonizes Nrf2-ARE pathway by depriving CBP from Nrf2 and facilitating recruitment of HDAC3 to MafK. Biochem Biophys Acta 1783(5):713\u2013727. https:\/\/doi.org\/10.1016\/j.bbamcr.2008.01.002","journal-title":"Biochem Biophys Acta"},{"issue":"5","key":"2485_CR41","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cellsig.2011.01.014","volume":"23","author":"M Yu","year":"2011","unstructured":"Yu M, Li H, Liu Q, Liu F, Tang L, Li C, Yuan Y, Zhan Y, Xu W, Li W, Chen H, Ge C, Wang J, Yang X (2011) Nuclear factor p65 interacts with Keap1 to repress the Nrf2-ARE pathway. Cell Signal 23(5):883\u2013892. https:\/\/doi.org\/10.1016\/j.cellsig.2011.01.014","journal-title":"Cell Signal"},{"issue":"5","key":"2485_CR42","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1007\/s11011-018-0256-9","volume":"33","author":"IO Ishola","year":"2018","unstructured":"Ishola IO, Akinyede AA, Adeluwa TP, Micah C (2018) Novel action of vinpocetine in the prevention of paraquat-induced parkinsonism in mice: involvement of oxidative stress and neuroinflammation. Metab Brain Dis 33(5):1493\u20131500. https:\/\/doi.org\/10.1007\/s11011-018-0256-9","journal-title":"Metab Brain Dis"},{"key":"2485_CR43","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ejphar.2017.08.027","volume":"814","author":"W Wadie","year":"2017","unstructured":"Wadie W, El-Tanbouly DM (2017) Vinpocetine mitigates proteinuria and podocytes injury in a rat model of diabetic nephropathy. Eur J Pharmacol 814:187\u2013195. https:\/\/doi.org\/10.1016\/j.ejphar.2017.08.027","journal-title":"Eur J Pharmacol"},{"key":"2485_CR44","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.phrs.2016.12.039","volume":"120","author":"V Fattori","year":"2017","unstructured":"Fattori V, Borghi SM, Guazelli CFS, Giroldo AC, Crespigio J, Bussmann AJC, Coelho-Silva L, Ludwig NG, Mazzuco TL, Casagrande R, Verri WA Jr (2017) Vinpocetine reduces diclofenac-induced acute kidney injury through inhibition of oxidative stress, apoptosis, cytokine production, and NF-kappaB activation in mice. Pharmacol Res 120:10\u201322. https:\/\/doi.org\/10.1016\/j.phrs.2016.12.039","journal-title":"Pharmacol Res"},{"key":"2485_CR45","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1476-4598-12-86","volume":"12","author":"B Hoesel","year":"2013","unstructured":"Hoesel B, Schmid JA (2013) The complexity of NF-kappaB signaling in inflammation and cancer. Mol Cancer 12:86. https:\/\/doi.org\/10.1186\/1476-4598-12-86","journal-title":"Mol Cancer"},{"issue":"51","key":"2485_CR46","doi-asserted-by":"publisher","first-page":"6680","DOI":"10.1038\/sj.onc.1209954","volume":"25","author":"TD Gilmore","year":"2006","unstructured":"Gilmore TD (2006) Introduction to NF-kappaB: players, pathways, perspectives. Oncogene 25(51):6680\u20136684. https:\/\/doi.org\/10.1038\/sj.onc.1209954","journal-title":"Oncogene"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-020-02485-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-020-02485-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-020-02485-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,15]],"date-time":"2021-05-15T23:35:32Z","timestamp":1621121732000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-020-02485-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,16]]},"references-count":46,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["2485"],"URL":"https:\/\/doi.org\/10.1007\/s11255-020-02485-z","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,16]]},"assertion":[{"value":"4 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The animal study was reviewed and approved by the Institutional Animal Care and Use Committee (IACUC) and the ABSL-3 Institutional Biosafety Committee (IBC). All experiments were performed in strict accordance with the recommendations of the National Institutes of Health Laboratory Animal Care and Use Guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}